Literature DB >> 27037929

Readmission in Cirrhosis: a Growing Problem.

Sakkarin Chirapongsathorn1,2, Jayant A Talwalkar1, Patrick S Kamath3.   

Abstract

OPINION STATEMENT: Patients with cirrhosis are at risk for several complications that require readmission. Readmissions are a direct burden on the patient and the family and are associated with negative outcomes to the patient, family, and health care system. Several recent studies have shown a high rate of readmission in patients with cirrhosis and a trend towards an increase in cost of health care delivery. Physicians and hospitals should recognize the patient at high risk for readmission not only at dismissal from hospital but also at admission. The Model for End-Stage Liver Disease (MELD) score may be used as a tool for risk stratification for readmission among patient with cirrhosis. Frailty, comorbidity, socioeconomic status, and type of health care delivery system are probable independent risk factors. Strategies to prevent readmission should target the high-risk patient.

Entities:  

Keywords:  Cirrhosis; Complications of cirrhosis; Costs; Health care delivery; MELD score; Readmission

Year:  2016        PMID: 27037929     DOI: 10.1007/s11938-016-0091-1

Source DB:  PubMed          Journal:  Curr Treat Options Gastroenterol        ISSN: 1092-8472


  17 in total

1.  Hospital readmissions among patients with decompensated cirrhosis.

Authors:  Michael L Volk; Rachel S Tocco; Jessica Bazick; Mina O Rakoski; Anna S Lok
Journal:  Am J Gastroenterol       Date:  2011-09-20       Impact factor: 10.864

2.  Incidence and predictors of 30-day readmission among patients hospitalized for advanced liver disease.

Authors:  Kenneth Berman; Sweta Tandra; Kate Forssell; Raj Vuppalanchi; Raj Vuppalanch; James R Burton; James Nguyen; Devonne Mullis; Paul Kwo; Naga Chalasani
Journal:  Clin Gastroenterol Hepatol       Date:  2010-11-17       Impact factor: 11.382

3.  Meta-analysis of alcohol intake in relation to risk of liver cirrhosis.

Authors:  G Corrao; V Bagnardi; A Zambon; P Torchio
Journal:  Alcohol Alcohol       Date:  1998 Jul-Aug       Impact factor: 2.826

4.  High risk of delisting or death in liver transplant candidates following infections: Results from the North American Consortium for the Study of End-Stage Liver Disease.

Authors:  K Rajender Reddy; Jacqueline G O'Leary; Patrick S Kamath; Michael B Fallon; Scott W Biggins; Florence Wong; Heather M Patton; Guadalupe Garcia-Tsao; Ram M Subramanian; Leroy R Thacker; Jasmohan S Bajaj
Journal:  Liver Transpl       Date:  2015-07       Impact factor: 5.799

5.  Guiding principles for the care of older adults with multimorbidity: an approach for clinicians: American Geriatrics Society Expert Panel on the Care of Older Adults with Multimorbidity.

Authors: 
Journal:  J Am Geriatr Soc       Date:  2012-09-19       Impact factor: 5.562

6.  Reducing inappropriate polypharmacy: the process of deprescribing.

Authors:  Ian A Scott; Sarah N Hilmer; Emily Reeve; Kathleen Potter; David Le Couteur; Deborah Rigby; Danijela Gnjidic; Christopher B Del Mar; Elizabeth E Roughead; Amy Page; Jesse Jansen; Jennifer H Martin
Journal:  JAMA Intern Med       Date:  2015-05       Impact factor: 21.873

Review 7.  A model to predict survival in patients with end-stage liver disease.

Authors:  P S Kamath; R H Wiesner; M Malinchoc; W Kremers; T M Therneau; C L Kosberg; G D'Amico; E R Dickson; W R Kim
Journal:  Hepatology       Date:  2001-02       Impact factor: 17.425

8.  Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis.

Authors:  Richard Moreau; Rajiv Jalan; Pere Gines; Marco Pavesi; Paolo Angeli; Juan Cordoba; Francois Durand; Thierry Gustot; Faouzi Saliba; Marco Domenicali; Alexander Gerbes; Julia Wendon; Carlo Alessandria; Wim Laleman; Stefan Zeuzem; Jonel Trebicka; Mauro Bernardi; Vicente Arroyo
Journal:  Gastroenterology       Date:  2013-03-06       Impact factor: 22.682

9.  A program to prevent functional decline in physically frail, elderly persons who live at home.

Authors:  Thomas M Gill; Dorothy I Baker; Margaret Gottschalk; Peter N Peduzzi; Heather Allore; Amy Byers
Journal:  N Engl J Med       Date:  2002-10-03       Impact factor: 91.245

10.  Socioeconomic costs of liver disease in Korea.

Authors:  Sunmi Lee; Woojin Chung; Kyung Rae Hyun
Journal:  Korean J Hepatol       Date:  2011-12
View more
  3 in total

1.  Cost-effectiveness of integrating gut microbiota analysis into hospitalisation prediction in cirrhosis.

Authors:  Jasmohan S Bajaj; Chathur Acharya; Masoumeh Sikaroodi; Patrick M Gillevet; Leroy R Thacker
Journal:  GastroHep       Date:  2020-02-06

2.  Acute decompensation boosts hepatic collagen type III deposition and deteriorates experimental and human cirrhosis.

Authors:  Michael Praktiknjo; Jennifer Lehmann; Mette J Nielsen; Robert Schierwagen; Frank E Uschner; Carsten Meyer; Daniel Thomas; Christian P Strassburg; Flemming Bendtsen; Søren Møller; Aleksander Krag; Morten A Karsdal; Diana J Leeming; Jonel Trebicka
Journal:  Hepatol Commun       Date:  2018-01-18

3.  Biomarkers and sociodemographic factors predicting one-year readmission among liver cirrhosis patients.

Authors:  Jingyi Dai; Jun Zhao; Yingrong Du; Edward B McNeil; Virasakdi Chongsuvivatwong
Journal:  Ther Clin Risk Manag       Date:  2019-08-08       Impact factor: 2.423

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.